FR3080765B1 - Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation - Google Patents

Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation Download PDF

Info

Publication number
FR3080765B1
FR3080765B1 FR1853845A FR1853845A FR3080765B1 FR 3080765 B1 FR3080765 B1 FR 3080765B1 FR 1853845 A FR1853845 A FR 1853845A FR 1853845 A FR1853845 A FR 1853845A FR 3080765 B1 FR3080765 B1 FR 3080765B1
Authority
FR
France
Prior art keywords
vitamin
salts
acid
derivative
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1853845A
Other languages
English (en)
Other versions
FR3080765A1 (fr
Inventor
Hugues Gatto
Jean-Noel Thorel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naos Institute of Life Science SAS
Original Assignee
Naos Institute of Life Science SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naos Institute of Life Science SAS filed Critical Naos Institute of Life Science SAS
Priority to FR1853845A priority Critical patent/FR3080765B1/fr
Priority to PCT/FR2019/051016 priority patent/WO2019211567A1/fr
Priority to CN201980044347.7A priority patent/CN112368367A/zh
Priority to EP19728488.8A priority patent/EP3788137A1/fr
Publication of FR3080765A1 publication Critical patent/FR3080765A1/fr
Application granted granted Critical
Publication of FR3080765B1 publication Critical patent/FR3080765B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composition cosmétique comprenant : - de l'acide α-lipoïque ou l'un de ses sels ; - un dérivé de vitamine C choisi parmi l'éthyle acide ascorbique et l'ascorbate de sodium ou leur mélange ; et - de l'acide hyaluronique.
FR1853845A 2018-05-04 2018-05-04 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation Active FR3080765B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1853845A FR3080765B1 (fr) 2018-05-04 2018-05-04 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
PCT/FR2019/051016 WO2019211567A1 (fr) 2018-05-04 2019-05-02 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
CN201980044347.7A CN112368367A (zh) 2018-05-04 2019-05-02 包含α-硫辛酸或α-硫辛酸盐、维生素C衍生物和透明质酸的组合物及其用途
EP19728488.8A EP3788137A1 (fr) 2018-05-04 2019-05-02 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1853845A FR3080765B1 (fr) 2018-05-04 2018-05-04 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
FR1853845 2018-05-04

Publications (2)

Publication Number Publication Date
FR3080765A1 FR3080765A1 (fr) 2019-11-08
FR3080765B1 true FR3080765B1 (fr) 2020-10-30

Family

ID=62948252

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1853845A Active FR3080765B1 (fr) 2018-05-04 2018-05-04 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation

Country Status (1)

Country Link
FR (1) FR3080765B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116410346A (zh) * 2021-12-31 2023-07-11 华熙生物科技股份有限公司 一种还原性透明质酸酯及其制备方法
WO2023235544A1 (fr) * 2022-06-03 2023-12-07 Colgate-Palmolive Company Compositions de soins cutanés et méthodes d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033689A1 (fr) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Composition dermatologique injectable pour le traitement des rides
FR3012329B1 (fr) * 2013-10-29 2017-02-10 Dermaconcept Jmc Association vitamine c et acide hyaluronique pour le traitement des effets du vieillissement cutane.
WO2016057513A1 (fr) * 2014-10-10 2016-04-14 Monibi Regina Formulation de soin cutané topique

Also Published As

Publication number Publication date
FR3080765A1 (fr) 2019-11-08

Similar Documents

Publication Publication Date Title
BR112015011497A2 (pt) composto, formulação farmacêutica, produto de combinação, e, método de tratamento de uma doença
EA201892734A1 (ru) ПРОИЗВОДНЫЕ АЗАБЕНЗИМИДАЗОЛА В КАЧЕСТВЕ ИНГИБИТОРОВ pI3K BETA
CR20170563A (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso.
MA38099A1 (fr) Des nouveaux composes triazolopyrazines substitues inhibiteurs des brd4
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
BR0309528A (pt) Comprimido com alta carga de droga
CU23105A3 (es) DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
BR0315580A (pt) Derivados de metileno uréia
CY1109843T1 (el) Αναλογα της βιταμινης d
FR3080765B1 (fr) Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
EA201992676A1 (ru) Фенильные производные в качестве модуляторов pge2 рецепторов
MX2021003999A (es) Moleculas de bajo peso molecular degradadoras de la proteina mdm2.
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
GEP20217279B (en) CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND THEIR USE
EA202192845A1 (ru) Новые композиции, содержащие мелфлуфен
TR201902057T4 (tr) Tetrasiklin bileşikleri.
CO2023005342A2 (es) Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer
MY194576A (en) Methods for the treatment of recurrent glioblastoma (rgbm)
RU2004124047A (ru) Композиция, ингибирующая матричные металлопротеиназы, предназначенная для лечения неопластических болезней
FR3053253B1 (fr) Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
MX358394B (es) Composicion cosmetica o dermatologica que comprende una merocianina, un agente de filtro ultravioleta b (uvb) organico y un agente de filtro ultravioleta a (uva) organico adicional.
BR0211237A (pt) Uso de derivados de aril (ou heteroaril) azolil-carbinóis para o tratamento de incontinência urinária e composição farmacêutica

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20191108

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

CL Concession to grant licences

Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR

Effective date: 20230724

AU Other action affecting the ownership or exploitation of an industrial property right

Effective date: 20231016

CL Concession to grant licences

Name of requester: NAOS, FR

Effective date: 20231016

Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR

Effective date: 20231016